Disease & disorder

corneal dystrophy

MONDO:0018102

The term corneal dystrophy embraces a heterogeneous group of bilateral genetically determined non-inflammatory corneal diseases that are usually restricted to the cornea. The designation is imprecise but remains in vogue because of its clinical value.

Clinical trials3

Recruiting1

Drug concepts studied0

Synonyms3

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…

Clinical trials

3 shown

High Resolution, High-speed Multimodal Ophthalmic ImagingNCT04129021 · 2019-07-03

AONDA Therapeutic Indication Study INCT05891106 · 2023-06-28

Corneal Endothelium Morphology and Central Thickness in Type II Diabetes Mellitus and Normal SubjectsNCT01084850 · 2009-06-01

Drugs being studied

Research locations

MemphisTennessee, United States1 OrlandoFlorida, United States1 ParisFrance1

Leading sponsors

Alcon Research1 Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts1 Frederiksberg University Hospital1

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.